Genomic Health, Inc. (NASDAQ:GHDX)
CAPS Rating:
A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.
RSS Headlines
Fool UK
Recs
I don't see ex-US growth and I don't believe in any of the new products.